Difference between revisions of "Adrenal cortical adenoma"

From Libre Pathology
Jump to navigation Jump to search
m (fix sp wikify)
 
(4 intermediate revisions by the same user not shown)
Line 9: Line 9:
| LMDDx      = adrenal cortical nodule, [[adrenal cortical hyperplasia]], [[adrenal cortical carcinoma]]
| LMDDx      = adrenal cortical nodule, [[adrenal cortical hyperplasia]], [[adrenal cortical carcinoma]]
| Stains    =
| Stains    =
| IHC        =
| IHC        = [[calretinin]], inhibin
| EM        =
| EM        =
| Molecular  =
| Molecular  =
Line 79: Line 79:
#High mitotic rate; >5/50 HPF (@ 40X obj.) - definition suffers from [[HPFitis]].
#High mitotic rate; >5/50 HPF (@ 40X obj.) - definition suffers from [[HPFitis]].
#Atypical mitoses.
#Atypical mitoses.
#Cleared cytoplasm in >= 25% of tumour cells.
#Cleared cytoplasm in <= 25% of tumour cells.
#Sheeting (diffuse architecture) in >= 1/3 of tumour cells.
#Sheeting (diffuse architecture) in >= 1/3 of tumour cells.
#Necrosis in nests.
#Necrosis in nests.
Line 97: Line 97:
Image: Adrenal LipoAdenoma MP PA.JPG|Adrenal cortical adenoma with fat - "lipoadenoma" (SKB)
Image: Adrenal LipoAdenoma MP PA.JPG|Adrenal cortical adenoma with fat - "lipoadenoma" (SKB)
</gallery>
</gallery>
==IHC==
Features:<ref name=pmid11893039>{{cite journal |authors=Jorda M, De MB, Nadji M |title=Calretinin and inhibin are useful in separating adrenocortical neoplasms from pheochromocytomas |journal=Appl. Immunohistochem. Mol. Morphol. |volume=10 |issue=1 |pages=67–70 |date=March 2002 |pmid=11893039 |doi=10.1097/00129039-200203000-00012 |url=}}</ref>
*[[Calretinin]] +ve.
*Inhibin +ve.
Note:
*Calretinin and inhibin in combination are useful for adrenal versus [[pheochromocytoma]].<ref name=pmid11893039/>


==Sign out==
==Sign out==
Line 102: Line 110:
Adrenal Gland, Right, Adrenalectomy:  
Adrenal Gland, Right, Adrenalectomy:  
- Adrenal cortical adenoma.  
- Adrenal cortical adenoma.  
</pre>
===Microscopic===
<pre>
The sections show a benign adrenal gland with an expanded cortex.
Clearing of the cytoplasm is present in the cortex.
None of the following are present in the cortex:
High nuclear grade, high mitotic rate (mitotic activity 1/50 HPF,
where 1 HPF~=0.2376 mm*mm), atypical mitoses, sheeting, necrosis,
sinusoidal invasion, venous invasion, capsular invasion.
</pre>
</pre>



Latest revision as of 14:38, 1 June 2020

Adrenal cortical adenoma
Diagnosis in short

Adrenal cortical adenoma. H&E stain.
LM DDx adrenal cortical nodule, adrenal cortical hyperplasia, adrenal cortical carcinoma
IHC calretinin, inhibin
Site adrenal gland

Prevalence relatively common
Radiology adrenal mass, HU<10
Prognosis benign
Treatment followup or surgical excision

Adrenal cortical adenoma, also adrenocortical adenoma and adrenal adenoma, is a relatively common benign pathology of the adrenal gland.

General

Epidemiology:

  • Often an incidental finding.

Pathologic/clinical:

  • Radiologists are good at identifying adenomas, as they are usually lipid rich and have a characteristic low HU signal (<10 HU[2]).
    • Microadenomas may be missed.[1][3]

Indications for excision:[4][5]

  • Lesions >30 mm.
  • Hormonally active.
  • Non-incidental finding. (???)
  • Adrenal vein sampling (AVS) suggestive of adenoma.[1]

Notes:

  • Cushing disease is due to the ACTH over-production by the pituitary.
  • In cortisol producing tumours (Cushing syndrome): atrophy of the non-hyperplastic cortex (due to feedback inhibition from the pituitary gland).

Microscopic

Classic features:

  • Well-defined cell borders.
  • Clear cells (abundant, finely vacuolated cytoplasm)
  • Polygonal pink cells.
  • Most of the nuclei are bland, central and round.
  • May have foci of necrosis/degeneration and nuclear atypia.

Note:

  • In aldosterone producing tumours:
    • May extend outside of the capsule (should not be diagnosed as adrenal cortical carcinoma).
    • No atrophy of non-hyperplastic cortex.
    • May show spironolactone bodies if hypertension treated with spironolactone prior to surgery.

DDx:

Weiss criteria

The diagnosis of adrenal cortical carcinoma requires three of the following:[8][9]

  1. High nuclear grade.
  2. High mitotic rate; >5/50 HPF (@ 40X obj.) - definition suffers from HPFitis.
  3. Atypical mitoses.
  4. Cleared cytoplasm in <= 25% of tumour cells.
  5. Sheeting (diffuse architecture) in >= 1/3 of tumour cells.
  6. Necrosis in nests.
  7. Venous invasion.
  8. Adrenal sinusoid invasion; lymphovascular space invasion within the adrenal gland.
  9. Capsular invasion.

Images

IHC

Features:[10]

Note:

Sign out

Adrenal Gland, Right, Adrenalectomy: 
- Adrenal cortical adenoma. 

Microscopic

The sections show a benign adrenal gland with an expanded cortex.
Clearing of the cytoplasm is present in the cortex.

None of the following are present in the cortex:
High nuclear grade, high mitotic rate (mitotic activity 1/50 HPF, 
where 1 HPF~=0.2376 mm*mm), atypical mitoses, sheeting, necrosis, 
sinusoidal invasion, venous invasion, capsular invasion.

See also

References

  1. 1.0 1.1 1.2 Myint, KS.; Watts, M.; Appleton, DS.; Lomas, DJ.; Jamieson, N.; Taylor, KP.; Coghill, S.; Brown, MJ. (Jun 2008). "Primary hyperaldosteronism due to adrenal microadenoma: a curable cause of refractory hypertension.". J Renin Angiotensin Aldosterone Syst 9 (2): 103-6. doi:10.3317/jraas.2008.015. PMID 18584586.
  2. Tenenbaum, F.; Lataud, M.; Groussin, L. (Apr 2014). "[Update in adrenal imaging].". Presse Med 43 (4 Pt 1): 410-9. doi:10.1016/j.lpm.2014.02.002. PMID 24636681.
  3. Fujiwara, M.; Murao, K.; Imachi, H.; Yoshida, K.; Muraoka, T.; Ohyama, T.; Kushida, Y.; Haba, R. et al. (Oct 2010). "Misdiagnosis of two cases of primary aldosteronism owing to failure of computed tomography to detect adrenal microadenoma.". Am J Med Sci 340 (4): 335-7. doi:10.1097/MAJ.0b013e3181e95587. PMID 20881759.
  4. Luton, JP.; Martinez, M.; Coste, J.; Bertherat, J. (Jul 2000). "Outcome in patients with adrenal incidentaloma selected for surgery: an analysis of 88 cases investigated in a single clinical center.". Eur J Endocrinol 143 (1): 111-7. PMID 10870039.
  5. Liu, XK.; Liu, XJ.; Dong, X.; Kong, CZ. (Jun 2008). "[Clinical research about treatment for adrenal incidentalomas]". Zhonghua Wai Ke Za Zhi 46 (11): 832-4. PMID 19035218.
  6. Thompson, Lester D. R. (2006). Endocrine Pathology: A Volume in Foundations in Diagnostic Pathology Series (1st ed.). Churchill Livingstone. pp. 200. ISBN 978-0443066856.
  7. IAV. 18 February 2009.
  8. Jain M, Kapoor S, Mishra A, Gupta S, Agarwal A (2010). "Weiss criteria in large adrenocortical tumors: a validation study". Indian J Pathol Microbiol 53 (2): 222–6. doi:10.4103/0377-4929.64325. PMID 20551521.
  9. Weiss, LM. (Mar 1984). "Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors.". Am J Surg Pathol 8 (3): 163-9. PMID 6703192.
  10. 10.0 10.1 Jorda M, De MB, Nadji M (March 2002). "Calretinin and inhibin are useful in separating adrenocortical neoplasms from pheochromocytomas". Appl. Immunohistochem. Mol. Morphol. 10 (1): 67–70. doi:10.1097/00129039-200203000-00012. PMID 11893039.